Delaying Emergence of Resistance to KRAS Inhibitors with Adaptive Therapy: “Treatment-to-Contain” Instead of “Treatment-to-Cure”-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Delaying Emergence of Resistance to KRAS Inhibitors with Adaptive Therapy: “Treatment-to-Contain” Instead of “Treatment-to-Cure”

Published:2022 Issue:2 Volume:24 Page:185-194
ISSN:1292-3818
Container-title:Oncologie
language:en
Short-container-title:

Author:

Imran Faisal Hamdi Amir,Stanslas Johnson

Publisher

Walter de Gruyter GmbH

Subject

Oncology

Reference60 articles.

1. The biology and management of non-small cell lung cancer;Herbst;Nature,2018

2. KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors

3. Genomic landscape of non-small cell lung cancer in smokers and never-smokers;Govindan;Cell,2012

4. Specific mutations in KRAS codon 12 are associated with worse overall survival in patients with advanced and recurrent colorectal cancer;Jones;British Journal of Cancer,2017

5. Sotorasib for lung cancers with KRAS p.G12C mutation;Skoulidis;The New England Journal of Medicine,2021

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adaptive therapy to circumvent drug resistance to tyrosine kinase inhibitors in cancer: is it clinically relevant?;Expert Review of Anticancer Therapy;2022-11-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP